Eric Warren - 19 Sep 2022 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Chief Commercial Officer
Signature
/s/ Sheldon L. Koenig, by power of attorney
Issuer symbol
ESPR
Transactions as of
19 Sep 2022
Transactions value $
-$1,765
Form type
4
Filing time
20 Sep 2022, 16:09:20 UTC
Previous filing
31 Aug 2022
Next filing
19 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale -$1.76K -255 -0.47% $6.92* 53.8K 19 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on quarterly vested shares of restricted stock units.